ArticleFrontiers in oncology2026
Case Report: Urachal inflammatory myofibroblastic tumor with bladder invasion.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Urachal inflammatory myofibroblastic tumor: a case report.Frontiers in oncology · 2026Article
- Inflammatory Myofibroblastic Tumor of the Urinary Bladder Presenting as a Radiological cT3 Mass: A Case Report and Narrative Review of 89 Cases.In vivo (Athens, Greece)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urachal inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm characterized by non-specific clinical and imaging features, which renders it susceptible to clinical misdiagnosis. Complete surgical resection is the preferred treatment method. Case presentation: We herein report a case of urachal IMT in a 12-year-old male child who presented with dysuria for 4 days and abnormal urine color for 2 days. Preoperative ultrasonography and contrast-enhanced computed tomography (CT) both suggested an infected urachal cyst. Laparoscopic resection of the urachal mass was initially performed; however, intraoperative exploration identified bladder invasion by the mass, prompting an additional partial cystectomy. Postoperative histopathological examination confirmed the diagnosis of urachal IMT with bladder invasion. No adjuvant therapy was administered postoperatively, and the patient remained free of recurrence and metastasis during a 6-month follow-up period. Conclusion: In the differential diagnosis of pediatric urachal lesions, IMT should be considered, especially when adjacent tissue invasion is present. Enhanced understanding of urachal IMT can assist clinicians in the early recognition and precise management of this tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.